-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr. -
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart AssociationKonstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia.
-
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative reviewBurlacu A, Simion P, Nistor I et al.
-
Circulating sST2 and catestatin levels in patients with acute worsening of heart failure: a report from the CATSTAT-HF studyJA Borovac, D Glavas, ZS Grabovac et al.
-
Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection FractionA Brann, S Janvanishstaporn, B Greenberg et al.
-
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunctionGoldberg LR, Jessup M.
-
Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients - A Systematic Review and Meta-AnalysisGA Hernandez, V Blumer, L Arcay et al.
-
2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure: A Report of the American College of Cardiology Solution Set Oversight CommitteeHollenberg SM, Warner Stevenson L, Ahmad T
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
